Global Neuroendovascular Coil Market Size Study & Forecast, By Product Type (Bare Metal Coil, Hydrogel Coated Coils) By Application (Aneurysm-Embolization, Malformation-Embolization, Ischemic Stroke-Revascularization, Stenosis-Revascularization), By End U

Global Neuroendovascular Coil Market Size Study & Forecast, By Product Type (Bare Metal Coil, Hydrogel Coated Coils) By Application (Aneurysm-Embolization, Malformation-Embolization, Ischemic Stroke-Revascularization, Stenosis-Revascularization), By End User (Hospitals, Forensic Laboratories, Stroke Center, Ambulatory Surgical Centers) and Regional Analysis, 2023-2030

Global Neuroendovascular Coil Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. A neuroendovascular coil, also known simply as an endovascular coil or detachable coil, is a medical device used in the minimally invasive treatment of cerebral aneurysms and other vascular abnormalities within the brain. These coils are typically made of platinum or other biocompatible materials and are designed to be delivered through a catheter into the blood vessels of the brain. Neuroendovascular coiling is considered a less invasive alternative to traditional surgical techniques for treating cerebral aneurysms. It offers several advantages, including shorter recovery times, reduced risk of complications, and avoidance of open brain surgery. Additionally, neuroendovascular coils can be used in conjunction with other endovascular techniques, such as stent-assisted coiling or flow diversion, to tailor treatment to the specific needs of each patient. The Neuroendovascular Coil market is expanding because of factors such as the increasing prevalence of neurovascular conditions, rising research and development activities, and the rise of minimally invasive procedures for neuroendovascular diseases.

The increasing prevalence of neurovascular conditions is a significant driver propelling the growth of the Neuroendovascular Coil Market. Neurovascular conditions, including cerebral aneurysms, arteriovenous malformations (AVMs), and intracranial hemorrhages, are becoming more prevalent globally due to factors such as aging populations, lifestyle changes, and improved diagnostic capabilities. As the incidence of these conditions rises, there is a growing demand for minimally invasive treatment options that offer effective and safe solutions. According to data published by the World Health Organization (WHO) in 2023, around 15.0 million people worldwide suffer a stroke, and coiling procedures are required to be performed to avoid permanent disability. Moreover, According to a report from the Alzheimer Disease International Organization, in the year 2020, globally around 55 million people were suffering from dementia and this figure is expected to reach 78 million in the year 2030 and 139 million by the year 2050. In addition, rising technological advancement and increasing awareness and education are creating new opportunities for market growth. However, the high cost of Neuroendovascular Coil stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Neuroendovascular Coil Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 propelled by the escalating incidence of brain disorders, notably brain aneurysms. This surge in demand for neuroendovascular devices and coils is attributed to the rising prevalence of such conditions. For example, in January 2021, as per statistics from the Centers for Disease Control and Prevention (CDC), approximately 800,000 individuals in the U.S. experienced a stroke each year, with over 75% of cases affecting individuals aged 65 years and older. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as the rising prevalence of neurological diseases, rising advancements in endovascular techniques, and favorable reimbursement policies in the region.

Major market players included in this report are:
Medtronic plc (Ireland)
Stryker Corporation (US)
Johnson & Johnson (Codman Neuro) (US)
Terumo Corporation (Japan)
Penumbra, Inc. (US)
MicroVention, Inc. (A subsidiary of Terumo Corporation) (US)
Balt Extrusion (France)
DePuy Synthes (a subsidiary of Johnson & Johnson) (US)
Cook Medical (US)
Acandis GmbH (Germany)

Recent Developments in the Market:
 In June 2023, Boston Scientific Corporation obtained FDA 510(k) clearance for its Embold Soft and Packing coils, tailored for diverse embolization procedures.
 In May 2023, Medical Device Business Services, Inc. (J&J MedTech) introduced its latest innovation, the CEREPAK Detachable Coils, designed for the treatment of brain aneurysms, marking its commercial debut in the U.S. market.

Global Neuroendovascular Coil Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered – Product Type, Application, End User, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the market's future growth. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product Type:
Bare Metal Coil
Hydrogel Coated Coils

By Application:
Aneurysm-Embolization
Malformation-Embolization
Ischemic Stroke-Revascularization
Stenosis-Revascularization
By End User:
Hospitals
Forensic Laboratories
Stroke Center
Ambulatory Surgical Centers
By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.